Matches in SemOpenAlex for { <https://semopenalex.org/work/W3209044447> ?p ?o ?g. }
- W3209044447 abstract "Background: Interactions between genetic and environmental risk factors (GxE) contribute to an increased risk of venous thromboembolism (VTE). Understanding how these factors interact provides insight for the early identification of at-risk groups within a population and creates an opportunity to apply appropriate preventive and curative measures. Objective: To estimate and compare GxE for VTE risk in the general Hungarian and Roma populations. Methods: The study was based on data extracted from a database consisting of results previously obtained from a complex health survey with three pillars (questionnaire-based, physical, and laboratory examinations) involving 406 general Hungarian and 395 Roma subjects. DNA was genotyped for rs121909567 (SERPINC1), rs1799963 (F2), rs2036914 (F11), rs2066865 (FGG), rs6025 (F5), and rs8176719 (ABO) polymorphisms. After allele frequency comparisons, the odds ratio (OR) was calculated for individual SNPs. Furthermore, genetic risk scores (weighted GRS, unweighted GRS) were computed to estimate the joint effect of the genetic factors. Multivariable linear regression analysis was applied to test the impact of GxE on VTE risk after interaction terms were created between genetic and VTE risk factors [diabetes mellitus (DM), cancer, chronic kidney diseases (CKD), coronary artery diseases (CAD), migraine, depression, obesity, total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high density lipoprotein (HDL-C), triglyceride (TG), and smoking]. Results: Interestingly, the rs121909567 (SERPINC1, ATBp3 mutation) SNP was not present in the general population at all. However, the risk allele frequency was 1% among the Roma population, which might suggest a founder effect in this minority. This polymorphism multiplicatively interacted with CAD, CKD, cancer, DM, depression, migraine, and obesity. Even though interactions were not statistically significant, the trend of interaction showed the probability of an incremental VTE risk among the Roma population. The risk of VTE was 4.7 times higher ( p > 0.05) for Roma subjects who had ≥3 wGRS (median value) compared with individuals having lower wGRS values but lower for the general subjects (OR = 3.1 × 10 −8 ). Additionally, the risk of VTE was 6.6 times higher in the Roma population that had ≥3 risk alleles (median value) than in individuals with the 0–1 risk allele, and the overall risk was much higher for the Roma population (OR = 6.6; p > 0.05) than for the general Hungarian population (OR = 1.5; p > 0.05). Five positive and significant GxE interactions were identified in the Roma population. The risk of VTE was higher among depressive Roma subjects who carried the risk variant rs2036914 (β = 0.819, p = 0.02); however, this interaction was not significant for the general subjects. The joint presence of high levels of LDL-C and rs2066865 (FGG) increased the VTE risk only among Roma individuals (β = 0.389, p = 0.002). The possibility of VTE risk increment, as a result of a multiplicative interaction between rs8176719 (ABO) and cancer, was identified, which was higher for the Roma population (β = 0.370, p < 0.001) than for the general population (β = −0.042, p = 0.6). The VTE risk increased in the Roma population (β = 0.280, p = 0.001), but was higher in the general population (β = 0.423, p = 0.001) as a result of the multiplicative interaction between CAD and rs2036914 (F11). The presence of a multiplicative interaction between rs2066865 (FGG) and CAD increased the VTE risk for the Roma population (β = 0.143, p = 0.046) but not for the general population (β = −0.329, p < 0.001). Conclusions: rs121909567 (SERPINC1, ATBp3) was confirmed as a founder mutation in the Roma population. Our study revealed some evidence on the burden of the joint presence of genetic and environmental risk factors on VTE, although the finding is highly subjected to the selection and observational biases due to the very small number of VTE cases and the observational nature of the study design, respectively. As a result of higher genetic load and GxE interactions, this minority Roma population is at higher risk of VTE than the general Hungarian population. Thus, our results suggest the need for an intensive search for the rs121909567 (SERPINC1; ATBp3) founder mutation, which might be an important factor for the assessment of thrombotic disease susceptibility among the Roma population. In addition, we strongly recommend further studies among a large number of VTE cases to explore the more precise impact of genetic and environmental risk factors on VTE in the study populations." @default.
- W3209044447 created "2021-11-08" @default.
- W3209044447 creator A5009554036 @default.
- W3209044447 creator A5015744608 @default.
- W3209044447 creator A5031776647 @default.
- W3209044447 creator A5040839445 @default.
- W3209044447 creator A5056653206 @default.
- W3209044447 creator A5058873202 @default.
- W3209044447 creator A5059864036 @default.
- W3209044447 creator A5087239691 @default.
- W3209044447 date "2021-10-26" @default.
- W3209044447 modified "2023-10-14" @default.
- W3209044447 title "The Higher Prevalence of Venous Thromboembolism in the Hungarian Roma Population Could Be Due to Elevated Genetic Risk and Stronger Gene-Environmental Interactions" @default.
- W3209044447 cites W1533494923 @default.
- W3209044447 cites W1597337165 @default.
- W3209044447 cites W1681995079 @default.
- W3209044447 cites W1861065888 @default.
- W3209044447 cites W1908633559 @default.
- W3209044447 cites W1964292893 @default.
- W3209044447 cites W1979420136 @default.
- W3209044447 cites W1984866007 @default.
- W3209044447 cites W1991630919 @default.
- W3209044447 cites W1993346276 @default.
- W3209044447 cites W1997402802 @default.
- W3209044447 cites W2001231775 @default.
- W3209044447 cites W2002267074 @default.
- W3209044447 cites W2007086823 @default.
- W3209044447 cites W2011378503 @default.
- W3209044447 cites W2015962018 @default.
- W3209044447 cites W2023804167 @default.
- W3209044447 cites W2025877869 @default.
- W3209044447 cites W2055657529 @default.
- W3209044447 cites W2067143182 @default.
- W3209044447 cites W2069166171 @default.
- W3209044447 cites W2075479448 @default.
- W3209044447 cites W2080839482 @default.
- W3209044447 cites W208923447 @default.
- W3209044447 cites W2093453252 @default.
- W3209044447 cites W2097981670 @default.
- W3209044447 cites W2099796420 @default.
- W3209044447 cites W2101404903 @default.
- W3209044447 cites W2101856540 @default.
- W3209044447 cites W2102347329 @default.
- W3209044447 cites W2110217083 @default.
- W3209044447 cites W2117991100 @default.
- W3209044447 cites W2128330231 @default.
- W3209044447 cites W2132797437 @default.
- W3209044447 cites W2146979553 @default.
- W3209044447 cites W2151983950 @default.
- W3209044447 cites W2157633587 @default.
- W3209044447 cites W2169109838 @default.
- W3209044447 cites W2169452705 @default.
- W3209044447 cites W2170237889 @default.
- W3209044447 cites W2186734985 @default.
- W3209044447 cites W2227346194 @default.
- W3209044447 cites W2294236942 @default.
- W3209044447 cites W2433608778 @default.
- W3209044447 cites W2469876530 @default.
- W3209044447 cites W2518007590 @default.
- W3209044447 cites W2533282048 @default.
- W3209044447 cites W2603085561 @default.
- W3209044447 cites W2604661412 @default.
- W3209044447 cites W2737232690 @default.
- W3209044447 cites W2739346979 @default.
- W3209044447 cites W2739641321 @default.
- W3209044447 cites W2748990043 @default.
- W3209044447 cites W2773481531 @default.
- W3209044447 cites W2792188134 @default.
- W3209044447 cites W2792403667 @default.
- W3209044447 cites W2861350639 @default.
- W3209044447 cites W2883123772 @default.
- W3209044447 cites W2931975650 @default.
- W3209044447 cites W2937963573 @default.
- W3209044447 cites W2943095529 @default.
- W3209044447 cites W2986831010 @default.
- W3209044447 cites W2989374653 @default.
- W3209044447 cites W3003636554 @default.
- W3209044447 cites W3014987048 @default.
- W3209044447 cites W3038809759 @default.
- W3209044447 cites W3042480030 @default.
- W3209044447 cites W3127622092 @default.
- W3209044447 cites W4242662082 @default.
- W3209044447 cites W84744743 @default.
- W3209044447 doi "https://doi.org/10.3389/fcvm.2021.647416" @default.
- W3209044447 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8576195" @default.
- W3209044447 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34765649" @default.
- W3209044447 hasPublicationYear "2021" @default.
- W3209044447 type Work @default.
- W3209044447 sameAs 3209044447 @default.
- W3209044447 citedByCount "4" @default.
- W3209044447 countsByYear W32090444472022 @default.
- W3209044447 countsByYear W32090444472023 @default.
- W3209044447 crossrefType "journal-article" @default.
- W3209044447 hasAuthorship W3209044447A5009554036 @default.
- W3209044447 hasAuthorship W3209044447A5015744608 @default.
- W3209044447 hasAuthorship W3209044447A5031776647 @default.
- W3209044447 hasAuthorship W3209044447A5040839445 @default.
- W3209044447 hasAuthorship W3209044447A5056653206 @default.
- W3209044447 hasAuthorship W3209044447A5058873202 @default.
- W3209044447 hasAuthorship W3209044447A5059864036 @default.